EMJ GOLD: Pharma news, views and analysis

In this episode, Sen and Kirstie discuss the increasingly influential Generation Z. They firstly analyse the unique characteristics of this population before looking at the methods pharma can use to engage them most effectively.

In this week's episode, Sen takes a look at some of the biggest news stories relating to the pharma industry in August. This includes reported sales revenue figures for Quarter 2 of this year as well as the announcement of major commercial agreements.

Spencer is joined by EMG's Head of Operations, Keith Moule, a former Team GB canoeist. They discuss how the lessons from working as a team in sport can be applied to business, drawing on personal experiences they've had in both areas.

This week, Sen and Kirstie meet up with Asad Mohsin Ali, General Manager of Ipsen's UK and Ireland office. Topics include Asad's unconventional route into pharma, leadership skills in pharma, working in different countries, and much more.

Sen is joined by a first timer to the podcast this week, our Editorial Administrator, Kirstie Turner, to discuss the content readers can expect from the upcoming edition of GOLD. They also reveal the infographic topic and who our catalyst interviewee is.

Head of Publishing Sen is back with a review of the month of July in pharma. In this episode, she takes a look at new appointments and updates of executive positions in the industry.

Spencer is joined by Dan to talk about the structure of EMG-Health's quarterly planning meetings. The pair discuss successes and challenges from the quarter and the main focus for the company in the next few months. 

This week, Spencer and Dan discuss the value of self-development books. They demonstrate the importance of reading as part of a self-development plan and analyse the books that have been particularly impactful to their personal growth so far this year.

In this week's episode, Spencer tells Dan about attending the brilliant ScaleUp Summit and the speakers that inspired him there. Spencer delves into the importance of trust, which was a popular topic at the event. 

This week, Sen takes a look back at news from the pharma industry in the month of June. In particular, she focusses on exciting new clinical trial results that were presented at a number of health conferences across various therapeutic areas.

This week, our Head of Publishing Sen takes us through Amy Nicole Nayar's fantastic talk, from the eyeforpharma Philadelphia event, on patient centricity, with a focus on communication within companies. 

Spencer, Sen, and Louise are all in the studio this week, as they discuss their experiences and highlights from this year's Cannes Lions conference. They also touch on what will be included in the review of the event, to be published in August. 

This week, Sen and Louise discuss the infographic published in the most recent edition of GOLD. This displays a breakdown of all new drug approvals by the EMA and FDA in 2018, highlighting examples of unique therapies now available for patients.

Sen is back with a review of the month of May in pharma. In this episode, she takes a look at the large number of investments and expansions announced within the industry in the past month.   

With the 2019 Cannes Lions conference just around the corner, Sen reflects on insights from two people we spoke to at last year's event: Gwenan White, UK Director of Communications at Abbvie and Eric Peacock, Co-Founder and CEO of MyHealthTeams.

On this week's episode, Sen and Louise discuss one of the biggest topics in the pharma industry right now: Gene and cell therapy. They outline the issues that pharma need to solve ensure these are accessible to all patients.

In this week's episode, Daniel De Schryver, Patient Engagement & Advocacy Lead, EMEA at Janssen, talks to us about his work in ensuring pharma collaborate increasingly closely with patients and the past experiences that drove this passion.

This week Sen and Louise discuss the upcoming issue of GOLD, which is out on the 30th May. They talk about some of the article topics taken from this year's eyeforpharma conference in Barcelona and reveal our catalyst interview for this edition. 

Sen is back in the hotseat for this week's episode as she reviews the month of April in pharma. She focusses on recent financial results in the industry and provides details of an innovative new pricing method that has been announced.

In this week's episode, Spencer is once again joined by Dan as the pair review the 7th Business Excellence Forum, held earlier this month in Telford, UK. They detail the speakers and messages that made the biggest impression on them.

Spencer is joined by a new face this week, EMG's Senior Project Director, Daniel Healy. The pair review the EMG's 5th Annual Company Ball from a few weeks ago, an event which included a talk from a Gold medal winning Olympian and the EMG Awards.

Neira from our design team debuts on the podcast this week, joining Sen in the hotseat. Together, they discuss the insights they gained from this year's Wired Health conference in London, an event which never fails to disappoint.

This week, Sen and Louise talk Brexit; in particular, the potential effect the UK's departure from the EU could have on the life-sciences sector, outlining insights from key stakeholders.

This week, Sen takes a look back at major stories that have taken place in the pharma industry in March. Partnership with tech companies was a big theme throughout the month, and Sen outlines some key examples and the impact these could have on patients.

In this week's episode, Spencer is joined by Louise to review the eyeforpharma conference in Barcelona that was attended by the EMG team earlier this month. Hear about the most important topics and themes that were discussed at the event.